Lim Chae-Seok, Yang Jung-Eun, Lee You-Kyung, Lee Kyungmin, Lee Jin-A, Kaang Bong-Kiun
Department of Biological Sciences, College of Natural Sciences, Seoul National University, Gwanangno 599, Seoul, Gwanak-gu, 151-747, Korea.
Department of Biological Sciences and Biotechnology, College of Life Science and NanoTechnology, Hannam University, Jeonmin-dong 461-6, Daejeon, Yuseong-gu, 305-811, Korea.
Mol Brain. 2015 Sep 30;8(1):57. doi: 10.1186/s13041-015-0146-6.
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by deficits in social cognition, language development, and repetitive/restricted behaviors. Due to the complexity and heterogeneity of ASD and lack of a proper human cellular model system, the pathophysiological mechanism of ASD during the developmental process is largely unknown. However, recent progress in induced pluripotent stem cell (iPSC) technology as well as in vitro neural differentiation techniques have allowed us to functionally characterize neurons and analyze cortical development during neural differentiation. These technical advances will increase our understanding of the pathogenic mechanisms of heterogeneous ASD and help identify molecular biomarkers for patient stratification as well as personalized medicine. In this review, we summarize our current knowledge of iPSC generation, differentiation of specific neuronal subtypes from iPSCs, and phenotypic characterizations of human ASD patient-derived iPSC models. Finally, we discuss the current limitations of iPSC technology and future directions of ASD pathophysiology studies using iPSCs.
自闭症谱系障碍(ASD)是一种复杂的神经发育障碍,其特征在于社会认知、语言发展以及重复/受限行为方面的缺陷。由于ASD的复杂性和异质性,以及缺乏合适的人类细胞模型系统,ASD在发育过程中的病理生理机制在很大程度上尚不清楚。然而,诱导多能干细胞(iPSC)技术以及体外神经分化技术的最新进展使我们能够对神经元进行功能表征,并分析神经分化过程中的皮质发育。这些技术进步将增进我们对异质性ASD致病机制的理解,并有助于识别用于患者分层以及个性化医疗的分子生物标志物。在本综述中,我们总结了我们目前对iPSC生成、从iPSC分化特定神经元亚型以及人类ASD患者来源的iPSC模型的表型特征的认识。最后,我们讨论了iPSC技术当前的局限性以及使用iPSC进行ASD病理生理学研究的未来方向。